(Date:12/1/2009)..., SAN DIEGO, Dec. 1 Aet...unced today that it will present at the LD MICRO C...m. (PST) at the Luxe Hotel in Los Angeles. Aethlon...present a corporate overview and will provide an u...ead product, the Hemopurifier®, a first-in-cl...
(Date:12/1/2009)...NAPOLIS and NORTH VANCOUVER, British Columbia, Dec..., a wholly owned subsidiary of The Dow Chemical Co...c. today announced the signing of a research and c...provides Dow AgroSciences with access to Agrisoma,...gy on an exclusive basis in major food crops, and ...
(Date:12/1/2009)...RANCISCO, Dec. 1 Medizon...nnounced today that in tests involving its proprie...reak "6 log" decontamination barriers, this time w...ustridium difficile and Bacillis subtilis. These r...remely potent sporicidal technology. "The implicat...
(Date:12/1/2009)...NTA, Dec. 1 GeoVax Labs..., an Atlanta-based, biopharmaceutical company deve... (Human Immunodeficiency Virus) and other infectio...IDS Day. ,, "Today is the 21st World AIDS Day a...r fight with the HIV/AIDS pandemic, we remain focu...
Breaking Biology Technology:Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6...TC-NCI-AACR Symposium --, SEATTLE and GENEVA, Oct...q: DNDN ) today presented preclinical data on its...ets Trp-p8 (a,transmembrane cation channel protein...rapeutic cancer target., The poster, titled, "Pre...Cancer/ Benign Prostate Hyperplasia Target," was p...
...United,Therapeutics Corporation (Nasdaq: UTHR ) a... quarter financial results before market open on,T...ill host a half-hour teleconference on Thursday,Oc...econference is,accessible by dialing 1-800-603-177...29. A rebroadcast of the teleconference will be av...
...rGen, Inc.,(Nasdaq: SUPG ), a pharmaceutical comp...novel cancer therapies, today presented data on MP...nal posters, at the 20th,EORTC-NCI-AACR Symposium ...Geneva, Switzerland. MP-470, an orally bio-availab...d encouraging tumor regression results in,the firs...
Other Biology Technology:Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist 2Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist 3SuperGen's MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 2SuperGen's MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 3SuperGen's MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy 4Rabbit Anti-Human NIRF Polyclonal Antibody, Unconjugated from Abcam
Alu I from New England Biolabs
Rabbit Anti-ZNF261 Polyclonal Antibody, Unconjugated from Abcam
SexA I from New England Biolabs
Biology Products: